InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Silva Francisco, Vice-Président. Director active across 1 companies, notably BioRestorative Therapies, Inc.. Cumulatively, 7 disclosures have been published. Total volume traded: €93k. The latest transaction was disclosed on 14 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
€952263 shares@ €3.6180.019% mcap1.0% of flow
Common Stock
SEC:0001567619-22-012893:0·
€2,455565 shares@ €4.34570.050% mcap2.6% of flow
Common Stock
SEC:0001567619-22-012496:0·
12,438 shares
Common Stock
SEC:0001567619-22-007349:0·
€23,4214,000 shares@ €5.855350.5% of flow
Common Stock
SEC:0001567619-21-020924·
Ideal exit: 16 Aug 2022 (T+270)
€23,4214,000 shares@ €5.85530.48% mcap24.3% of flow
Common Stock
SEC:0001567619-21-020924:0·
Ideal exit: 16 Aug 2022 (T+270)
€22,9903,826 shares@ €6.008949.5% of flow
Common Stock
SEC:0001567619-21-020585·
Ideal exit: 13 Aug 2022 (T+270)
€22,9903,826 shares@ €6.00890.47% mcap23.9% of flow
Common Stock
SEC:0001567619-21-020585:0·
Ideal exit: 13 Aug 2022 (T+270)
7 of 7 declarations
About Silva Francisco
Francisco Silva is Vice President of Research and Development at BioRestorative Therapies, Inc. He oversees the company's research and development initiatives, aiming to innovate and enhance products. His expertise in R&D is essential for the success of the organization.
